中文FrançaisDeutsch日本語Русский языкEspañolعربيEsperanto한국어BIG5
CHINA DEVELOPMENT GATEWAY
SiteMap Feedback
Travel Living in China Archaeology Film Learning Chinese Chinatown Suppliers
Home China International Business Government Education Environment Culture Women Books & Magazines Sports Health Entertainment
Home / Health / News Tools: Save | Print | E-mail | Most Read
Fake Drug Victims Set to File Landmark Lawsuit
Adjust font size:  ZoomIn ZoomOut

Ten people are set to file a landmark joint lawsuit against the Second Pharmaceutical Company in Qiqihar, northeast China's Heilongjiang Province, for producing a fake drug called Armillarisin. They intend to sue the company for a record 10 million-plus yuan in compensation for producing a drug that inflicted serious liver damage and claimed eleven lives.
 
Guangzhou Daily reports the lawsuit will be the first lawsuit a group of fake drug victims has filed against a pharmaceutical company. The action comes after a series of fake drug scandals in China.
 
The Second Pharmaceutical Company manufactured Armillarisin in conjunction with a chemicals plant in Taixing in east China's Jiangsu Province. The toxic brew was marketed as an injection designed to cure gall bladder disease and other digestive disorders, but it caused kidney failure and killed eleven people. The survivors were forced to spend large sums of money on kidney transplants and related treatments.
 
The newspaper reports the police investigation is ongoing and the main suspect has been placed in custody. He has confessed the company and chemical plant replaced one of the ingredients required in the injection, propanediol, with 1.2 tons of industrial-grade diglycol.

The attorney for the victims, who are all from Guangzhou, says he will help other attorneys launch bigger lawsuits on behalf of other fake drug victims after the current appeal.

Before the Armillarisin case, a scandal erupted over the lack of quality control in Chinese pharmaceuticals after a fake antibiotic called "Xinfu" claimed at least ten lives in 2006.
 
The Guangzhou Daily quotes another attorney who says repeated fake drug scandals have exposed loopholes in the way China monitors and regulates the manufacture and sale of drugs. He says more stringent monitoring and enforcement mechanisms must be established across the country. Tougher compensation laws should apply to companies caught producing fake drugs.

(CRI March 21, 2007)

Tools: Save | Print | E-mail | Most Read

Related Stories
Court Turns Down Lawsuit for Xinfu Victims
Fake Viagra Pills Seized at Customs
Defective Antibiotic Xinfu Claims 11
Medicine Authorities Crack Down on Fake Drugs
Shenzhen Targets Pharmacies Selling Fake Drugs
Potentially Hazardous Injection Linked to Six Deaths
SiteMap | About Us | RSS | Newsletter | Feedback
SEARCH THIS SITE
Copyright ? China.org.cn. All Rights Reserved ????E-mail: webmaster@china.org.cn Tel: 86-10-88828000 京ICP證 040089號
主站蜘蛛池模板: 88久久精品无码一区二区毛片| 啊灬啊灬别停啊灬用力啊| A级国产乱理论片在线观看| 无码国模国产在线观看| 久久综合五月婷婷| 欧美另类视频videosbest18| 伊人狠狠色丁香综合尤物| 巨胸狂喷奶水视频www网站免费| 好妻子韩国片在线| 中文字幕人成乱码中文乱码| 日韩一级在线观看| 亚洲精品美女久久7777777| 香港三级绝色杨贵妃电影| 国产福利高颜值在线观看| 6080理论片国产片| 在线视频网址免费播放| yellow2019电影在线高清观看 | 日本aⅴ日本高清视频影片www| 国产精品美女久久久网站动漫| 99久久久精品免费观看国产| 女人张开腿让男人桶个爽| 久久精品国产久精国产一老狼 | 亚洲国产日韩精品| 欧美视频在线播放bbxxx| 国产v亚洲v天堂a无| 阿娇囗交全套高清视频| 国产婷婷综合在线视频中| chinese帅哥18kt| 日本免费一二区在线电影| 久久精品国产亚洲AV网站| 最新中文字幕在线| 亚洲精品不卡视频| 激情综合丝袜美女一区二区| 国产一区二区精品久久91| 青娱乐精品视频在线观看| 国产在线观看精品一区二区三区91 | 人人做人人爽人人爱| 男人与禽交的方法| 俄罗斯精品bbw| 玉蒲团之风雨山庄| 亚洲黄色在线观看视频|